Tests brain stimulation with a device to aid movement recovery after stroke
Tests a device sending gentle electrical signals to the brain in stroke survivors.
Plain-language title generated from the registry record
Registry title: tACS for Sensory Motor Recovery After Stroke
Key facts
- Where
- Houston, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06029062, who can take part
Where in United States
- The University of Texas Health Science CenterHouston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Texas Health Science Center, Houston
- Trial code
- NCT06029062
- Record updated
- 3 June 2026
- Original description
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.Read full original descriptionShow less
tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.
Inclusion: Age between 18~75 years old; ≥ 6 months post stroke, medically stable; Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); Visible finger flexor activation/movement; The ability to give consent.
Exclusion: Patients that are currently adjusting tone alternating medications (e.g., baclofen), or; Patients received botulinum toxin injection to the arm/fingers <4 months, or phenol injections <2 years; Patients with pacemaker, metal implants or supplemental oxygen; Patients with visual deficit/neglect; hearing or cognitive impairment; Patients who have musculoskeletal disorders, including pain in the affected side; Women who are pregnant.
Inclusion/exclusion criteria for stroke subjects.